Record tools

Copy identifiers or export this single peptide record for a local research note.

Back to browser

PEPDIA-INT-017934

Silver

Sinapultide

65

Quality

2

Source DBs

4

Activities

4

Source refs

1

Literature

0

Patents

Integrated record

Sequence and molecular profile

KLLLLKLLLLKLLLLKLLLLK
Indexed sequence21 aa
1KLLLLKLLLLKLLLLKLLLLK

Length

21

Molecular weight

2469.45 Da

Formula

C126H238N26O22

Structure type

Linear

Synthesis

-

Chirality

-

Family

-

Gene

-

Residue composition

L
16
K
5

Physicochemical profile

Hydrophobic16

Membrane affinity proxy

Polar0

Solubility proxy

Charged5

Net charge proxy +5

Aromatic0

Binding interaction proxy

Versioned scientific descriptors

Physicochemical properties and standard representations

calculated sequence and structure

Reported properties

Legacy compatibility fields are materialized from the versioned PepDiana computed release; no separate source-reported property is available.

Computed properties

physchem-20260620

Molecular weight

2469.3984 Da

Molecular formula

C126H238N26O22

Theoretical pI

10.6025

Net charge at pH 7

4.7551

GRAVY

1.9667

Instability index

-22.819

Aromaticity

0

Topological polar surface area

775.42 Ų

cLogP

6.4769

Hydrogen-bond donors

27

Hydrogen-bond acceptors

27

Rotatable bonds

93

Method: PepDiana sequence/structure descriptor pipeline

Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6

Calculated: 2026-06-20T11:01:38.358971+00:00

Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200

Sequence representations

representations-20260620 · RDKit 2024.09.6

ProForma 2.0

validated simple linear

KLLLLKLLLLKLLLLKLLLLK

HELM 2.0

validated simple linear

PEPTIDE1{K.L.L.L.L.K.L.L.L.L.K.L.L.L.L.K.L.L.L.L.K}$$$$V2.0

Canonical SMILES

validated

CC(C)CC(NC(=O)C(N)CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O

Isomeric SMILES

validated

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

Follow-up research

External analysis tools

Research workflow

Citation and local history

BibTeX

@misc{PEPDIA-INT-017934,
  title = {Sinapultide},
  author = {{PepDiana Consortium}},
  year = {2026},
  howpublished = {PepDiana Multifunctional Peptide Database},
  url = {http://127.0.0.1:3004/peptides/PEPDIA-INT-017934},
  note = {Accessed from local PepDiana development build}
}

APA-style note

Sinapultide. (2026). PepDiana record PEPDIA-INT-017934. PepDiana Multifunctional Peptide Database. http://127.0.0.1:3004/peptides/PEPDIA-INT-017934

This record is saved to local recent-view history so it can reappear on the peptide browser page.

Integrated source-database annotations

Biological activity (4 records)

Stable recordActivitySubtypeValueTargetAssay methodSource
CTPDB_P017934_ACT_peptherdia_0000Clinical / Approved DrugGeneral TherapeuticNot available in the current structured importUnknownNot reported by source10peptherdia / linked
CTPDB_P017934_ACT_thpdb_0001Clinical / Approved DrugGeneral TherapeuticNot available in the current structured importUnknownNot reported by sourceTh1146_10669_rec0thpdb / unavailable
CTPDB_P017934_ACT_thpdb_0002Clinical / Approved DrugGeneral TherapeuticNot available in the current structured importUnknownNot reported by sourceTh1146_10670_rec1thpdb / unavailable
CTPDB_P017934_ACT_thpdb_0003Clinical / Approved DrugGeneral TherapeuticNot available in the current structured importUnknownNot reported by sourceTh1146_10671_rec2thpdb / unavailable

Provenance

Source database records (4)

peptherdia

10

Raw sequence

KLLLLKLLLLKLLLLKLLLLK

thpdb

Th1146_10669_rec0

Raw sequence

KLLLLKLLLLKLLLLKLLLLK

thpdb

Th1146_10670_rec1

Raw sequence

KLLLLKLLLLKLLLLKLLLLK

thpdb

Th1146_10671_rec2

Raw sequence

KLLLLKLLLLKLLLLKLLLLK

Citation trail

Literature (1 records)

[{"text": "drugbank.com", "url": "https://go.drugbank.com/drugs/DB11332", "markdown": "[drugbank.com](https://go.drugbank.com/drugs/DB11332)"}, {"text": "fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf", "markdown": "[fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf)"}, {"text": "ncats.io", "url": "https://drugs.ncats.io/drug/040X3AX99T", "markdown": "[ncats.io](https://drugs.ncats.io/drug/040X3AX99T)"}]

[{"text": "drugbank.com", "url": "https://go.drugbank.com/drugs/DB11332", "markdown": "[drugbank.com](https://go.drugbank.com/drugs/DB11332)"}, {"text": "fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf", "markdown": "[fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf)"}, {"text": "ncats.io", "url": "https://drugs.ncats.io/drug/040X3AX99T", "markdown": "[ncats.io](https://drugs.ncats.io/drug/040X3AX99T)"}]

--

Audit surface

Raw annotations and release metadata

Integrated record last updated: 2026-04-15T00:59:21.345173+00:00

Modification summary

No structured modification annotations are available for this record.

ADMET
{
  "toxicity": [
    {
      "source_db": "thpdb",
      "assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
      "toxicity_type": "Toxicity"
    },
    {
      "source_db": "thpdb",
      "assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
      "toxicity_type": "Toxicity"
    },
    {
      "source_db": "thpdb",
      "assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
      "toxicity_type": "Toxicity"
    }
  ]
}
Source metadata
[
  {
    "source_db": "peptherdia",
    "organism_name": "Unknown"
  },
  {
    "source_db": "thpdb",
    "organism_name": "Unknown"
  }
]
Clinical trials
[
  {
    "status": "Therapeutic",
    "drug_name": "Sinapultide",
    "source_db": "peptherdia",
    "indication": "Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.",
    "approval_year": 2012,
    "approval_agency": "FDA",
    "administration_route": "IT"
  }
]
Approved drug annotations
{
  "status": "Therapeutic",
  "drug_name": "Sinapultide",
  "source_db": "peptherdia",
  "indication": "Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.",
  "approval_year": 2012,
  "approval_agency": "FDA",
  "administration_route": "IT"
}